ADPT Adaptive Biotech Future Profit
Adaptive Biotechnologies monetizes AI-driven immunity analysis through high-margin SaaS access to its T-cell database. Analyst earnings expectations confirm this potential, with the mark reflecting the latest data. Growth is protected by unique bioinformatics patents, while operational flexibility is ensured by the efficient use of cloud computing for genome processing, which minimizes capital expenditures.
Analytical breakdowns for Adaptive Biotechnologies
- share price and consensus valuation forecast:
- market capitalization data:
- book capitalization information:
- company total debt and liquidity indicators:
Debt to Equity Adaptive Biotechnologies|ADPT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Adaptive Biotechnologies Corp|ADPT - Company Aggregate Debts|Debt to Book Capitalization Ratio Adaptive Biotechnologies|ADPT - Company Long-Term Indebtedness|Company Short-Term Debts Adaptive Biotechnologies|Quick Ratio adaptivebiotech.com
- earnings and valuation multiples information:
ADPT - Net Profit|Projected Future Earnings Adaptive Biotechnologies|ADPT - Price to Earnings Multiple|Forward P/E Multiple Adaptive Biotechnologies Corporation|ADPT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies|ADPT - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Adaptive Biotechnologies|ADPT - Earnings per share for the last four quarters|Quarterly EPS earnings growth adaptivebiotech.com|ADPT - Expected net earnings per share growth this year|Expected earnings per share growth for next year Adaptive Biotechnologies
- revenue and sales details:
Basic company analysis:ADPT, Adaptive Biotechnologies
This indicator captures the impact of currency fluctuations on the expected revenues of export-oriented businesses, eliminating random spikes through a strict daily calculation. The current cash return forecast for Adaptive Biotechnologies (ADPT) at allows for the separation of the company's operational resilience from market noise, confirming the effectiveness of large-scale investments in AI-driven immune system mapping and precision diagnostics.
Competing companies
ARGX (argenx SE) - Projected Future Earnings|Projected Future Earnings biontech.de|Future Profit ABVX (Abivax Corp)|ADMA (ADMA Biologics Inc) - Expected Net Income|Projected Future Earnings PTGX (Protagonist Therapeutics Inc)|Company Profit Forecast Immunovant Therapeutics (IMVT)|KNSA - Expected Profit|grifols.com (GRFS) - Future Profit|Celldex Therapeutics, Inc. (CLDX) - Expected Profit|Future Profit Aurinia Pharmaceuticals Inc|Future Profit BCRX|Projected Future Earnings Vera Corp|Expected Profit Dianthus Therapeutics (DNTH)|pharvaris.com - Net Profit Forecast|Projected Future Earnings ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Expected Net Profit|Intrexon - Projected Future Earnings|PHAR - Projected Future Earnings|NKTR: Projected Future Earnings|Net Profit Forecast UPB|ZBIO (Zenas Biopharma) - Projected Future Earnings|Projected Future Earnings Immunome Inc|Expected Profit Gossamer Corp (GOSS)|KALV: Forward Earnings|Septerna Inc - Future Profit|Future Net Profit PVLA (pieris.com)|Savara - Projected Future Earnings|Company Profit Forecast Rigel Pharma RIGL|ANAB (AnaptysBio Corp) - Future Profit|ATXS (Astria Corp) - Expected Profit|ENGN (enGene Holdings Inc.) - Projected Future Earnings|Expected Net Profit rapt.com RAPT|Future Profit JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Expected Net Income|Projected Future Earnings KYTX (Kyverna)|Tiziana Life Sciences, Ltd. - Expected Profit|Cabaletta Bio, Inc. - Projected Future Earnings|Company Profit Forecast ventyxbio.com VTYX|Theratechnologies (THTX) - Expected Profit|Expected Net Profit Avalo Therapeutics, Inc. (AVTX)|Future Profit ELDN|AGEN (Agenus, Inc) - Future Net Profit|Projected Future Earnings CLYM|ZURA - Expected Net Profit|Projected Future Earnings ATYR (aTyr Pharma)|ADAG - Future Profit|Ikena Oncology, Inc. - Projected Future Earnings|Expected Net Income STTK (Shattuck Labs, Inc.)|equilliumbio.com (EQ) - Expected Profit|Net Profit Forecast CNTB|Expected Profit Immunic Therapeutics|Expected Net Profit Atara Biotherapeutics Inc ATRA|Expected Profit InflaRx N.V. (IFRX)|Expected Profit XFOR (X4 Pharmaceuticals, Inc)|Expected Profit Adicet Bio, Inc. ACET|Celularity Inc (CELU) - Expected Net Profit|INmune Bio - Projected Future Earnings|Projected Net Profit Barinthus Biotherapeutics PLC (BRNS)|KZR: Projected Future Earnings|SABS - Company Profit Forecast|AKTX (Akari Therapeutics) - Projected Future Earnings|Expected Net Profit Enlivex Therapeutics, Ltd. ENLV|Expected Profit Q32 Bio Inc. (QTTB)|Company Profit Forecast GeoVax Labs|Projected Future Earnings EDSA (Edesa)|Projected Future Earnings iBio Corporation IBIO|Carisma Tx - Projected Future Earnings|XTLB (xtlbio.com) - Net Profit Forecast|boltbio.com (BOLT) - Expected Profit|Forward Earnings HCWB (HCW Biologics)|Future Profit APVO|AIM (aimimmuno.com) - Future Net Profit|Expected Profit Aditxt (ADTX)|GRI: Forward Earnings|Projected Future Earnings XRTX (XORTX Therapeutics)|Expected Net Income HIND|Revelation Bio - Projected Future Earnings|INDP - Projected Future Earnings|Scinai Immunotherapeutics (SCNI) - Expected Profit|CalciMedica - Expected Net Income|Expected Profit Affimed NV|Future Profit Allakos Therapeutics (ALLK)|Projected Future Earnings HOOK|Projected Future Earnings igmbio.com (IGMS)|iTeos Therapeutics - Future Profit|Expected Net Income OCEA|TC BioPharm - Projected Future Earnings|Company Profit Forecast Third Harmonic Bio Inc. THRD
